Insider · CIK 0001180429
KAILIAN VAUGHN M
Reports to the SEC for 14 companies · BOSTON, MA
Transactions
50
Companies
14
Filings
6
CIK
0001180429
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2013-03-11 | PCRXPacira BioSciences, Inc.S Sale | −$13.9M |
| 2012-02-08 | PCRXPacira BioSciences, Inc.C Conversion | — |
| 2012-02-08 | PCRXPacira BioSciences, Inc.C Conversion | — |
| 2012-02-08 | PCRXPacira BioSciences, Inc.P Purchase | +$1.87M |
| 2012-02-08 | PCRXPacira BioSciences, Inc.P Purchase | +$1.87M |
| 2012-02-08 | PCRXPacira BioSciences, Inc. · Series A Convertible Preferred StockC Conversion | — |
| 2012-02-08 | PCRXPacira BioSciences, Inc. · Convertible Promissory NoteC Conversion | — |
| 2011-11-21 | PCRXPacira BioSciences, Inc.P Purchase | +$3M |
| 2011-10-14 | CEPHALON INCNon-Qualified Stock OptionD Disposition to Issuer | — |
| 2011-10-14 | CEPHALON INCNon-Qualified Stock OptionD Disposition to Issuer | — |
| 2011-10-14 | CEPHALON INCNon-Qualified Stock OptionD Disposition to Issuer | — |
| 2011-10-14 | CEPHALON INCNon-Qualified Stock OptionD Disposition to Issuer | — |
| 2011-10-14 | CEPHALON INCNon-Qualified Stock OptionD Disposition to Issuer | — |
| 2011-10-14 | CEPHALON INCNon-Qualified Stock OptionD Disposition to Issuer | — |
| 2011-10-14 | CEPHALON INCNon-Qualified Stock OptionD Disposition to Issuer | — |
| 2011-05-10 | CEPHALON INCNon-Qualified Stock OptionA Award | — |
| 2011-02-08 | PCRXPacira BioSciences, Inc.C Conversion | — |
| 2011-02-08 | PCRXPacira BioSciences, Inc.C Conversion | — |
| 2011-02-08 | PCRXPacira BioSciences, Inc.P Purchase | +$1.87M |
| 2011-02-08 | PCRXPacira BioSciences, Inc.P Purchase | +$1.87M |
| 2011-02-08 | PCRXPacira BioSciences, Inc. · Series A Convertible Preferred StockC Conversion | — |
| 2011-02-08 | PCRXPacira BioSciences, Inc. · Convertible Promissory NoteC Conversion | — |
| 2010-05-20 | CEPHALON INCNon-Qualified Stock OptionA Award | — |
| 2009-11-11 | PEPLIN INCD Disposition to Issuer | — |
| 2009-11-11 | PEPLIN INCWarrants (right to buy)D Disposition to Issuer | — |
| 2009-11-11 | PEPLIN INCWarrants (right to buy)D Disposition to Issuer | — |
| 2009-11-11 | PEPLIN INCWarrants (right to buy)D Disposition to Issuer | — |
| 2009-05-12 | CEPHALON INCNon-Qualified Stock OptionA Award | — |
| 2009-02-12 | PEPLIN INCP Purchase | +$10.2K |
| 2009-02-11 | PEPLIN INCP Purchase | +$7,992 |
| 2009-02-09 | PEPLIN INCP Purchase | +$7,992 |
| 2009-02-05 | PEPLIN INCP Purchase | +$20.7K |
| 2009-01-27 | PEPLIN INCP Purchase | +$7,584 |
| 2009-01-27 | PEPLIN INCP Purchase | +$6,132 |
| 2009-01-23 | PEPLIN INCP Purchase | +$48.2K |
| 2009-01-22 | PEPLIN INCP Purchase | +$10.2K |
| 2009-01-22 | PEPLIN INCP Purchase | +$10.7K |
| 2009-01-21 | PEPLIN INCP Purchase | +$7,456 |
| 2009-01-20 | PEPLIN INCP Purchase | +$378 |
| 2009-01-19 | PEPLIN INCP Purchase | +$7,371.8 |
| 2009-01-16 | PEPLIN INCP Purchase | +$60.2K |
| 2009-01-15 | PEPLIN INCP Purchase | +$12.5K |
| 2009-01-13 | PEPLIN INCP Purchase | +$48.6K |
| 2009-01-01 | MEMORY PHARMACEUTICALS CORPU Disposition from Tender | −$8.62M |
| 2007-09-14 | MEMORY PHARMACEUTICALS CORPS Sale | −$58K |
| 2007-09-13 | MEMORY PHARMACEUTICALS CORPS Sale | −$132K |
| 2007-09-12 | MEMORY PHARMACEUTICALS CORPS Sale | −$21.6K |
| 2007-06-30 | MEMORY PHARMACEUTICALS CORPJ Other | — |
| 2007-02-28 | MEMORY PHARMACEUTICALS CORPJ Other | — |
| 2005-05-18 | CEPHALON INCNon-Qualified Stock Option (right to buy)A Award | — |
Recent filings
- 4KAILIAN VAUGHN M0001209191-13-016172SEC(opens sec.gov)
- 4KAILIAN VAUGHN M0001209191-11-057584SEC(opens sec.gov)
- 4KAILIAN VAUGHN M0001209726-11-000005SEC(opens sec.gov)
- 4KAILIAN VAUGHN M0001374636-11-000008SEC(opens sec.gov)
- 4/AKAILIAN VAUGHN M0001209191-11-010535SEC(opens sec.gov)
- 4KAILIAN VAUGHN M0001209191-11-008428SEC(opens sec.gov)
Companies
- ARATANA THERAPEUTICS, INC.10% Owner
- Avalo Therapeutics, Inc.10% OwnerAVTX
- CEPHALON INCDirector
- CHIASMA, INC10% Owner
- Epizyme, Inc.10% Owner
- Histogen Inc.10% Owner
- MEMORY PHARMACEUTICALS CORPDirector, 10% Owner
- MILLENNIUM PHARMACEUTICALS INCDirector
- Pacira BioSciences, Inc.Former 10% OwnerPCRX
- PEPLIN INC10% Owner
- Radius Health, Inc.Former 10% stockholder
- Syndax Pharmaceuticals Inc10% OwnerSNDX
- Verastem, Inc.Former 10% stockholderVSTM
- VIACELL INCDirector
Address
C/O MPM ASSET MANAGEMENT 200 CLARENDON STREET, 54TH FLOOR
BOSTON, MA, 02116